This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated FTH1 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-FTH1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~21.2 kDa | |
| Observed band | ~19 kDa | |
| Gel | 5–20% (catalog M02401) | |
| Positive control | Bone marrow (IHC candidate; verify WB) +4 more | |
| Negative control | Parathyroid gland (IHC candidate; verify WB) |
| PTM | Phosphorylated + Acetylated | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 1 isoform(s) |
The M02401 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | human Hela, human 293T, human MCF-7 (catalog M02401) |
| Gel % | 5–20% (catalog M02401) |
| Load | 30 ug; reducing conditions (catalog M02401) |
| Transfer | a nitrocellulose membrane at 150 mA for 50-90 minutes (catalog M02401) |
| Membrane | nitrocellulose membrane (catalog M02401) |
| Blocking | 5% non-fat milk/TBS for 1.5 hour at RT (catalog M02401) |
| Primary antibody | M02401 · 1:500 (catalog M02401) |
| Primary incubation | overnight at 4°C (catalog M02401) |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:500 (catalog M02401) |
| Secondary incubation | 1.5 hour at RT (catalog M02401) |
| Wash | TBS-0.1%Tween 3 times with 5 minutes each (catalog M02401) |
| Detection | ECL (catalog M02401) |
FTH1 is predicted at 21.2 kDa and observed near 19 kDa in reducing blots; the cause of the difference is not established.
| Band near 19 kDa | Empirical FTH1 band observed in reducing whole-cell and tissue lysates |
| Band near 21.2 kDa | Near the UniProt predicted mass; confirm identity with an antibody control |
| Closely spaced bands near the main band | Could reflect the listed N-terminal processing or phosphorylation, but distinct migration is unproven |
| Additional lower band | May warrant checking N-terminal processing or degradation; no fragment size is established |
| High-mass band under poorly dissociating conditions | Could reflect persistence of the listed 24-subunit ferritin complex |
| UniProt predicted mass | 21.2 kDa for FTH1; antibody QC observes approximately 19 kDa |
| N-terminal processing at Thr2 | Removes the initiating residue; no measurable migration effect is established |
| N-terminal acetylation at Met1 or processed Thr2 | Is documented, but no visible size shift is established |
| Phosphoserine 179 | May alter migration, but no distinct band is demonstrated |
| Phosphoserine 183 | May alter migration, but no distinct band is demonstrated |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | FTH1 is listed in cytoplasm, lysosome, and autophagosomes; absence from whole-cell lysate has no established feature-specific explanation | Check lysate quality and an FTH1-positive control |
| Band higher than expected | The listed 24-subunit complex may persist if dissociation is incomplete | Check denaturation conditions and compare with a reducing control |
| Band lower than expected | The observed band is approximately 19 kDa versus a 21.2 kDa prediction; its offset is unexplained | Compare with the QC band and confirm identity using an independent antibody or FTH1 depletion |
| Multiple bands | N-terminal processing and phosphorylation are listed, but distinct bands are unproven | Confirm each band with an independent antibody or FTH1 depletion |
| Weak or no signal | FTH1 detection may depend on sample abundance and fraction selection | Check loading, antibody performance, and a positive lysate |
| Fragments below expected size | No defined FTH1 fragment mass is supplied | Check sample integrity and use an independent antibody to assess identity |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Bone marrow | hematopoietic cells | High | Protein (IHC) | HPA → |
| Caudate | glial cells | High | Protein (IHC) | HPA → |
| Cerebral cortex | glial cells | High | Protein (IHC) | HPA → |
| Breast | glandular cells | Medium | Protein (IHC) | HPA → |
| Colon | peripheral nerve/ganglion | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Parathyroid gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Adipose tissue | adipocytes | Low | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Low | Protein (IHC) | HPA → |
| Appendix | glandular cells | Low | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | Low | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for FTH1, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Two the supplier rabbit monoclonal antibodies are listed for FTH1 Western blotting. M02401 has a blot image showing a band near 19 kDa in the named human, rat, and mouse samples; M02401-2 has a HeLa lysate blot image. No publication evidence is supplied.
Which to pick: Choose M02401 for its reported human, mouse, and rat reactivity and blot image across named samples from all three species. M02401-2 reports human reactivity and shows a HeLa lysate blot; consider it for that context.